PSC
RGEN icon

Piper Sandler & Co’s Repligen RGEN Stock Holding History

Piper Sandler & Co’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1
Closed – – 25
2019
Q3 		$0 Buy
+1
New +$87 ﹤0.01% 25

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Piper Sandler & Co's RGEN Position: Q4 2019 in Review

Piper Sandler & Co sold out of Repligen (RGEN) in Q4 2019, closing a stake of 1 share.

Piper Sandler & Co first reported a position in RGEN in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 306 funds tracked by Wall St. Rank hold RGEN as of Q4 2019.

  • Piper Sandler & Co reported no remaining Repligen position as of Q4 2019 after selling out during the quarter.
  • Piper Sandler & Co sold 1 Repligen share in Q4 2019.
  • Piper Sandler & Co first reported a position in Repligen in Q3 2019 and held it in 1 quarter.
  • Piper Sandler & Co's Repligen position peaked at $0 in Q3 2019.
  • 306 funds tracked by Wall St. Rank held Repligen as of Q4 2019.

Based on Piper Sandler & Co's 13F filing for Q4 2019, filed 14 Feb 2020.